Vivien Wong

Vivien Wong possesses extensive experience in drug development and research leadership. Currently serving as Executive Vice President of Research & Development at Progenics Pharmaceuticals since 2007, Vivien oversees all drug development functions, including clinical, manufacturing, regulatory, and nonclinical development, along with quality assurance. Prior to this role, Vivien founded Theritas LLC and held senior positions at Emisphere Technologies and VivoQuest, Inc., focusing on drug development and preclinical efforts. Early career experience includes an Associate Director role at Regeneron Pharmaceuticals and a Post-Doctoral Fellowship at the Albert Einstein College of Medicine. Vivien Wong holds a PhD in Neurobiology from the University of Maryland School of Medicine.